跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
DASATINIB ACCORD 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
DASATINIB ACCORD 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Accord Healthcare S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 13, 2022
Approval ID
e4a6266eb2e6ea44
Company
Accord Healthcare S.L.U.
Type
Standard
Approval Details
Approval Id
e4a6266eb2e6ea44
Drug Cima Aemps Name
DASATINIB ACCORD 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
1211540007
Holder Company Name
Accord Healthcare S.L.U.
Marketing Company Name
Accord Healthcare S.L.U.
Holder Company Detail Path
/organization/accord-healthcare-sl
Marketing Company Detail Path
/organization/accord-healthcare-sl
Authorization Date
2022-06-13
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Accord Healthcare S.L.U.
Company Detail Path
/organization/accord-healthcare-sl
Company Information
Pharmaceutical Company Name
ACCORD HEALTHCARE SL
Country Name
Spain
City Name
barcelona,barcelona,country_es
Address
CALLE MOLL BARCELONA (WORLD TRADE CENTER EDIF. ESTE), S/N
Active Ingredients
DASATINIB
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 13, 2022
Approval ID
e4a6266eb2e6ea44
Type
Standard
Back to CIMA-AEMPS Approvals
DASATINIB ACCORD 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
